Risk Factors of 30-Day All-Cause Mortality in Patients with Carbapenem-Resistant <i>Klebsiella pneumoniae</i> Bloodstream Infection
An optimal antimicrobial regimen for the treatment of patients with carbapenem-resistant <i>Klebsiella pneumoniae</i> (CRKP) bloodstream infection (BSI) is currently unavailable. This study aimed to identify the appropriate antibiotics and the risk factors of all-cause mortality for CRKP...
Main Authors: | Keh-Sen Liu, Yao-Shen Tong, Ming-Tsung Lee, Hung-Yu Lin, Min-Chi Lu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-06-01
|
Series: | Journal of Personalized Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4426/11/7/616 |
Similar Items
-
Molecular Characterization of Carbapenem Resistant <i>Klebsiella pneumoniae</i> in Malaysia Hospital
by: Min Yi Lau, et al.
Published: (2021-03-01) -
Carbapenem-Resistant <em>Klebsiella pneumoniae</em> Associated with COVID-19
by: Irina Magdalena Dumitru, et al.
Published: (2021-05-01) -
Risk factors for KPC-producing Klebsiella pneumoniae bacteremia
by: Felipe F. Tuon, et al. -
Acquisition of Plasmid with Carbapenem-Resistance Gene blaKPC2 in Hypervirulent Klebsiella pneumoniae, Singapore
by: Yahua Chen, et al.
Published: (2020-03-01) -
Carbapenem-Resistant <i>Klebsiella pneumoniae</i> Infections in ICU COVID-19 Patients—A Scoping Review
by: Wioletta Mędrzycka-Dąbrowska, et al.
Published: (2021-05-01)